Barclays Joins Bulls as EW Heads Toward October Earnings

The bull case centres on the structural heart franchise, particularly TMTT, where sales grew 48.3% year on year in the most recent print and where management has guided for $740 to $780 million in full-year 2026 revenue. TAVR growth of 10.6% also beat consensus, and the company has set revenue targets of $6.4 to $6.8 billion for the year. The bear case is less about the top line and more about margins: adjusted operating margin came in at 23.7% against an expectation of 25.9%, and elevated SG&A spending has raised questions about whether the cost structure can support the growth ambitions. Valuation gives the bears some cover. The P/E stands near 26x, EV/EBITDA near 20x, and both multiples have drifted lower over the past month, meaning the stock is being modestly de-rated even as growth expectations hold. The EV/EBIT factor ranks in the 27th percentile, so the value case is thin.

Short interest at 1.6% of float is too low to be a primary story. What little there is has been broadly flat for weeks, with the 30-day change a small negative. Borrow conditions are correspondingly easy: availability is extremely loose at 8,064%, meaning roughly 80 shares remain available for every one currently lent, and the cost to borrow at 0.52% is barely above its floor for the year. The ORTEX short score of 30.6 has barely moved in a fortnight. None of this signals short-side pressure. Options positioning shows modest defensiveness, with the put/call ratio at 1.03, a touch above its 20-day average of 0.98, but the z-score of 0.68 puts it well within normal territory. Collectively, the positioning picture looks neutral rather than charged in either direction.

The ownership register is dominated by the largest passive managers. BlackRock reported a stake of around 10.2% as of September 30, adding 6.2 million shares in its most recent disclosure. JP Morgan Asset Management added 1.3 million shares, also as of September 30. Insider activity over the past 90 days shows a net negative in shares, but the transactions are small and mostly compensation-related: tax withholding sales (transaction code F) and pre-arranged 10b5-1 plan exercises, the kind of routine activity that carries little informational weight. There is no 13D activist on the register.

Wikipedia attention for Edwards is running 1.8 standard deviations above its own 90-day average on a log scale, a reading the ORTEX Alt Data layer flags as elevated retail interest. This dataset has not been measured as a lead for the company's reported financials, so it is colour rather than a signal, but it is consistent with a stock that is drawing more eyes than usual heading into an event. The nearest comparable peer by correlation, ISRG, has moved almost identically on the week at minus 1.8%, while IDXX and DXCM have fallen harder, down 3.4% and 3.8% respectively, suggesting the mild pressure on EW this week is broadly sector-driven rather than company-specific.

The last earnings print, Q2, saw the stock fall 2.1% the next day before recovering 3% over the following five days. With the October 23 report now the focal point, the key question is whether the margin story has improved enough to validate the bullish price targets, or whether SG&A pressure will again dominate the headline despite a solid top-line beat.